Marc Botteman

• Quality-adjusted survival of nivolumab plus ipilimumab or nivolumab alone versus ipilimumab alone among treatment-naive patients with advanced melanoma

  Open Access•David F McDermott, Ruchit Shah et al.•ARTICLE•Quality of Life Research•2018

  Incluir item

• Quality of life of patients with Fabry disease

  Open Access•Karen Gold, K F Gold et al.•ARTICLE•Quality of Life Research•2002

  Incluir item

• Quality of life of patients with Fabry disease

  Open Access•Karen Gold, K F Gold et al.•ARTICLE•Quality of Life Research•2002

  Incluir item

• Quality-adjusted survival of nivolumab plus ipilimumab or nivolumab alone versus ipilimumab alone among treatment-naive patients with advanced melanoma

  Open Access•David F McDermott, Ruchit Shah et al.•ARTICLE•Quality of Life Research•2018

  Incluir item

Internal Medicine (2 obras) · Medicine (2 obras) · Adverse effect (1 obras) · Biosimilars and Bioanalytical Methods (1 obras) · Cancer (1 obras) · Cancer Immunotherapy and Biomarkers (1 obras) · CAR-T cell therapy research (1 obras) · Disease (1 obras) · Enzyme replacement therapy (1 obras) · Fabry disease (1 obras)